Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported in Q3 CY2025, with sales up 20% year on year to $850.7 ...

Mail-in stool kits such as Colorguard can detect warning signs, but gastroenterologists say a colonoscopy is still the most ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

In a troubling intersection of aggressive medical marketing and privacy concerns, thousands of Americans are receiving unrequested colon cancer screening tests at their doorsteps, a practice that has ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

When Erica Barnell was an MD/PhD student at Washington University in St. Louis, she met a woman who had stage four colorectal cancer (CRC). The woman was only 52 years old—more than a decade younger ...

Scream actor Matt Lillard is working with Exact Sciences, the makers of Cologuard, for the "Screen" campaign to increase colon cancer screening awareness. Here Lillard answers the door in a filmed ...

"I think it's going to do a lot of good," the 'Scream' star tells PEOPLE of his new ad for Cologuard Monica Schipper/GA/The Hollywood Reporter via Getty Matthew Lillard advocates for colon cancer ...

“No need to scream when you can screen,” says a Cologuard delivery person in a :60 spot starring Matthew Lillard, famous for being one of the serial killers in the 1996 film “Scream.” Cologuard “takes ...

As Halloween approaches, Exact Sciences is warding off a particularly terrifying occurrence: skipping colorectal cancer screening. A newly launched campaign touts the company’s Cologuard test as a non ...

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer ...